바로가기메뉴

본문 바로가기 주메뉴 바로가기

Difference in Protein Markers According to the Survival of Sepsis Patients Using Protein Chips

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.61 no.1, pp.41-45








  • Downloaded
  • Viewed

Abstract

Background; Several clinical scoring systems are currently being used to predict the outcome of sepsis, but they all have certain limitations. Therefore, we sought to identify the proteomic biomarkers, with wsing proteomic tools, that differed according to the outcome of sepsis patients.Methods; Upon admission to the ICU, blood samples were obtained from the 16 patients with sepsis who were enrolled in this study. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI TOF MS) was used to identify the markers that could predict the outcome of sepsis.Results; We found six peaks, by using cation and anion chips, that statistically differed between those patients who died and those who survived.Conclusion; The biomarkers we found by using proteomic tools may help predict the prognosis and also plan the treatment of sepsis. (Tuberc Respir Dis 2006; 61: 41-45)

keywords
Sepsis, Treatment outcome, Proteomics., Sepsis, Treatment outcome, Proteomics.

Reference

1.

Annane D,, (2005) Septic shock,

2.

Hotchkiss RS, (2003) The pathophysiology and treatment of sepsis.,

3.

Knaus WA, a severity of disease classification system. Crit Care Med 198513,

4.

Knaus WA, risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991100,

5.

le Gall JR, et al. A simplified acute physiology score for ICU patients. Crit Care Med 198412,

6.

Gage RW. Refining intensive care unit outcome prediction by using changing probabilities of mortality. Crit Care Med 198816,

7.

de Rooji SE, (2005) Factors that predict outcome of intensive care treatment in very elderly patients: a review,

8.

Livingston BM, (2000) Assessment of the performance of five intensive care scoring models within a large Scottish databases.,

9.

Polderman KH, (1999) Interobserver variability in the use of APACHE II score.,

10.

Morales IJ, (2003) Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.,

11.

Rosenberg AL, (2003) Accepting critically ill transfer patients: adverse effect on a referral center?s outcome and benchmark measures,

12.

Petricoin EF 3rd,, (2002) Serum proteomic patterns for detection of prostate cancer.,

13.

Petricoin EF,, (2002) Use of proteomic patterns in serum to identify ovarian cancer.,

14.

Papadopoulos MC, (2004) A novel and accurate diagnostic test for human African trypanosomiasis.,

15.

Zhu XD, (2004) New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology,

16.

Burchardi H,, (2004) Economic aspects of severe sepsis a review of intensive care unit costs cost of illnessand cost effectiveness of therapy.,

17.

Ahn WS, (2005) Identification of hemoglobin-? and ?? subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.,

18.

Ilyin SE, (2004) Biomarker discovery and validation: technologies and integrative approaches.,

19.

Rodland KD, (2004) Proteomics and cancer diagnosis: the potential of mass spectrometry,

20.

Christ-Crain M,, (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster- randomised, single-blinded intervention trial,

21.

Colonna M, (2003) TREM-1: A new player in acute inflammatory responses,

22.

Scherpereel A, (2006) Endocan, a new endothelial marker in human sepsis,

Tuberculosis & Respiratory Diseases